Screen Testing

Wilder, 1950 Bax, 2006, The potential of myocardial perfusion scintigraphy for risk stratification of asymptomatic patients with type 2 diabetes, J Am Coll Cardiol, 48, 754, 10.1016/j.jacc.2006.04.077 Miller, 2006, Screening asymptomatic diabetic patients for coronary artery disease, J Am Coll Cardiol, 48, 761, 10.1016/j.jacc.2006.04.076 Sackett, 1985, Early diagnosis, 144 Sackett, 1985, How to read a clinical journal, 302 HVPA Cost Comparison—Statins/Statin Combos June 2006. Available at: http://www.hvpa.com/hvpa_rx_drug_cost_tables_files/statin_cost_comparisons_0606upd.pdf. Accessed July 27, 2006. Physician Fee Schedule. Available at: http://www.cms.hhs.gov/PhysicianFeeSched/. Accessed July 27, 2006. 2005 1994, Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S), Lancet, 344, 1383 2002, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomized placebo-controlled trial, Lancet, 360, 7, 10.1016/S0140-6736(02)09327-3 2006, 92 Grover, 2001, How cost-effective is the treatment of dyslipidemia in patients with diabetes but without cardiovascular disease?, Diabetes Care, 24, 45, 10.2337/diacare.24.1.45 Koch, 1998 Wackers, 2004, Detection of silent myocardial ischemia in asymptomatic diabetic subjects, Diabetes Care, 27, 1954, 10.2337/diacare.27.8.1954 Rajagopalan, 2005, Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging, J Am Coll Cardiol, 45, 43, 10.1016/j.jacc.2004.06.078 Zellweger, 2004, Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients, Eur Heart J, 25, 543, 10.1016/j.ehj.2004.02.013 Barsness, 2006, Rationale for the revascularization arm of the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial, Am J Cardiol, 97, 31G, 10.1016/j.amjcard.2006.03.011 Naghavi, 2006, From vulnerable plaque to vulnerable patient—part III: executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report, Am J Cardiol, 98, 2H, 10.1016/j.amjcard.2006.03.002 Pfutzner, 2006, High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus, Diabetes Technol Ther, 8, 28, 10.1089/dia.2006.8.28 Clinton, 1993, Executive Order 12866, 58, 51735 Diamond, 2006, Hazardous to your health, Am J Med, 119, 275, 10.1016/j.amjmed.2005.07.020